Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms

Kourtis, 2019, Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections - United States, MMWR Morb Mortal Wkly Rep, 68, 214, 10.15585/mmwr.mm6809e1 Boucher, 2008, Epidemiology of methicillin-resistant Staphylococcus aureus, Clin Infect Dis, 46, S344, 10.1086/533590 Magill, 2018, Changes in prevalence of health care-associated infections in U.S. Hospitals, N Engl J Med, 379, 1732, 10.1056/NEJMoa1801550 Olaniyi, 2017, Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis, Curr Top Microbiol Immunol, 409, 199 Bjarnsholt, 2013, The in vivo biofilm, Trends Microbiol, 21, 466, 10.1016/j.tim.2013.06.002 Bjarnsholt, 2009, Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients, Pediatr Pulmonol, 44, 547, 10.1002/ppul.21011 Sonderholm, 2017, The consequences of being in an infectious biofilm: microenvironmental conditions governing antibiotic tolerance, Int J Mol Sci, 18, 10.3390/ijms18122688 Stewart, 2008, Physiological heterogeneity in biofilms, Nat Rev Microbiol, 6, 199, 10.1038/nrmicro1838 Stewart, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 Lewis, 2001, Riddle of biofilm resistance, Antimicrob Agents Chemother, 45, 999, 10.1128/AAC.45.4.999-1007.2001 Mah, 2001, Mechanisms of biofilm resistance to antimicrobial agents, Trends Microbiol, 9, 34, 10.1016/S0966-842X(00)01913-2 Crabbe, 2019, Antimicrobial tolerance and metabolic adaptations in microbial biofilms, Trends Microbiol, 27, 850, 10.1016/j.tim.2019.05.003 Lewis, 2010, Persister cells, Annu Rev Microbiol, 64, 357, 10.1146/annurev.micro.112408.134306 Kohanski, 2010, How antibiotics kill bacteria: from targets to networks, Nat Rev Microbiol, 8, 423, 10.1038/nrmicro2333 Waters, 2016, Convergence of Staphylococcus aureus persister and biofilm Research: can biofilms Be defined as communities of adherent persister cells?, PLoS Pathog, 12, 10.1371/journal.ppat.1006012 Wood, 2013, Bacterial persister cell formation and dormancy, Appl Environ Microbiol, 79, 7116, 10.1128/AEM.02636-13 Lewis, 2008, Multidrug tolerance of biofilms and persister cells, Curr Top Microbiol Immunol, 322, 107 Wood, 2017, Strategies for combating persister cell and biofilm infections, Microb Biotechnol, 10, 1054, 10.1111/1751-7915.12774 Conlon, 2013, Activated ClpP kills persisters and eradicates a chronic biofilm infection, Nature, 503, 365, 10.1038/nature12790 Radlinski, 2019, Chemical induction of aminoglycoside uptake overcomes antibiotic tolerance and resistance in Staphylococcus aureus, Cell Chem Biol., 26, 1355, 10.1016/j.chembiol.2019.07.009 Bauer, 2013, A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms, Antimicrob Agents Chemother, 57, 2726, 10.1128/AAC.00181-13 Radlinski, 2017, Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus, PLoS Biol, 15, 10.1371/journal.pbio.2003981 Singh, 2010, Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms, J Antimicrob Chemother, 65, 1955, 10.1093/jac/dkq257 Singh, 2016, Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain- and antibiotic-specific differences, Pathog Dis, 74, 10.1093/femspd/ftw056 Goltermann, 2017, Importance of the exopolysaccharide matrix in antimicrobial tolerance of Pseudomonas aeruginosa aggregates, Antimicrob Agents Chemother, 61, 10.1128/AAC.02696-16 Tseng, 2013, The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin, Environ Microbiol, 15, 2865, 10.1111/1462-2920.12155 Oberli, 2014, Ultrasound-enhanced transdermal delivery: recent advances and future challenges, Ther Deliv, 5, 843, 10.4155/tde.14.32 Konofagou, 2012, Ultrasound-induced blood-brain barrier opening, Curr Pharmaceut Biotechnol, 13, 1332, 10.2174/138920112800624364 Church, 2001, “Stable” inertial cavitation, Ultrasound Med Biol, 27, 1435, 10.1016/S0301-5629(01)00441-0 Tzu-Yin, 2013, Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications, Curr Pharmaceut Biotechnol, 14, 743 Mugabe, 2005, Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients, J Antimicrob Chemother, 55, 269, 10.1093/jac/dkh518 Meers, 2008, Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections, J Antimicrob Chemother, 61, 859, 10.1093/jac/dkn059 Kim, 2020, A comparison of sonothrombolysis in aged clots between low-boiling-point phase-change nanodroplets and microbubbles of the same composition, Ultrasound Med Biol, 46, 3059, 10.1016/j.ultrasmedbio.2020.07.008 Helfield, 2020, Investigating the accumulation of submicron phase-change droplets in tumors, Ultrasound Med Biol, 46, 2861, 10.1016/j.ultrasmedbio.2020.06.021 Fix, 2018, Accelerated clearance of ultrasound contrast agents containing polyethylene glycol is associated with the generation of anti-polyethylene glycol antibodies, Ultrasound Med Biol, 44, 1266, 10.1016/j.ultrasmedbio.2018.02.006 Burgess, 2015, Acoustic cavitation-mediated delivery of small interfering ribonucleic acids with phase-shift nano-emulsions, Ultrasound Med Biol, 41, 2191, 10.1016/j.ultrasmedbio.2015.04.002 Williams, 2013, Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer, Ultrasound Med Biol, 39, 475, 10.1016/j.ultrasmedbio.2012.10.004 Fix, 2017, An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro, J Ther Ultrasound, 5, 7, 10.1186/s40349-017-0085-z Sheeran, 2012, Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons, Biomaterials, 33, 3262, 10.1016/j.biomaterials.2012.01.021 Nyankima, 2018, In vivo assessment of the potential for renal bio-effects from the vaporization of perfluorocarbon phase-change contrast agents, Ultrasound Med Biol, 44, 368, 10.1016/j.ultrasmedbio.2017.10.016 Chiang, 2013, Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 57, 2352, 10.1128/AAC.00001-13 Qian, 1996, Effect of low-intensity ultrasound upon biofilm structure from confocal scanning laser microscopy observation, Biomaterials, 17, 1975, 10.1016/0142-9612(96)00022-1 Young, 1990, Macrophage responsiveness to therapeutic ultrasound, Ultrasound Med Biol, 16, 809, 10.1016/0301-5629(90)90045-E Zhou, 2008, Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src/MAPKs activity, Cell Signal, 20, 695, 10.1016/j.cellsig.2007.12.005 Fix, 2019, Ultrasound-stimulated phase-change contrast agents for transepithelial delivery of macromolecules, toward gastrointestinal drug delivery, Ultrasound Med Biol, 45, 1762, 10.1016/j.ultrasmedbio.2019.02.004 Hughes, 1980, Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase, Biochem J, 191, 209, 10.1042/bj1910209 Healy, 2000, Vancomycin resistance in enterococci: reprogramming of the D-ala-D-Ala ligases in bacterial peptidoglycan biosynthesis, Chem Biol, 7, R109, 10.1016/S1074-5521(00)00116-2 Barcia-Macay, 2006, Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus, J Antimicrob Chemother, 58, 1177, 10.1093/jac/dkl424 Schwalm, 2004, Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment, Can J Infect Dis, 15, 97 Hashimoto, 2018, Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies, J Pharm Health Care Sci, 4, 27, 10.1186/s40780-018-0123-1 Grein, 2020, Ca(2+)-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids, Nat Commun, 11, 1455, 10.1038/s41467-020-15257-1 Lechner, 2012, Staphylococcus aureus persisters tolerant to bactericidal antibiotics, J Mol Microbiol Biotechnol, 22, 235 Raad, 2007, Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm, Antimicrob Agents Chemother, 51, 1656, 10.1128/AAC.00350-06 Liu, 2011, Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary, Clin Infect Dis, 52, 285, 10.1093/cid/cir034 Pasquaroli, 2014, Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms, Pathogens, 3, 759, 10.3390/pathogens3030759 Pasquaroli, 2013, Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms, J Antimicrob Chemother, 68, 1812, 10.1093/jac/dkt086 Negut, 2018, Treatment strategies for infected wounds, Molecules, 23, 10.3390/molecules23092392 Fair, 2014, Antibiotics and bacterial resistance in the 21st century, Perspect Med Chem, 6, 25 Bartlett, 2013, Seven ways to preserve the miracle of antibiotics, Clin Infect Dis, 56, 1445, 10.1093/cid/cit070 Lattwein, 2020, Sonobactericide: an emerging treatment strategy for bacterial infections, Ultrasound Med Biol, 46, 193, 10.1016/j.ultrasmedbio.2019.09.011 Ronan, 2016, USMB-induced synergistic enhancement of aminoglycoside antibiotics in biofilms, Ultrasonics, 69, 182, 10.1016/j.ultras.2016.03.017 Hu, 2018, The synergistic bactericidal effect of vancomycin on UTMD treated biofilm involves damage to bacterial cells and enhancement of metabolic activities, Sci Rep, 8, 192, 10.1038/s41598-017-18496-3 Guo, 2017, Stimulated phase-shift acoustic nanodroplets enhance vancomycin efficacy against methicillin-resistant Staphylococcus aureus biofilms, Int J Nanomed, 12, 4679, 10.2147/IJN.S134525 Chang, 2017, Low-frequency ultrasound debridement in chronic wound healing: a systematic review of current evidence, Plast Surg (Oakv), 25, 21, 10.1177/2292550317693813 Ilovitsh, 2020, Low-frequency ultrasound-mediated cytokine transfection enhances T cell recruitment at local and distant tumor sites, Proc Natl Acad Sci U S A, 117, 12674, 10.1073/pnas.1914906117 Ilovitsh, 2018, Enhanced microbubble contrast agent oscillation following 250 kHz insonation, Sci Rep, 8, 16347, 10.1038/s41598-018-34494-5 Kennedy, 2008, Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification, Proc Natl Acad Sci, 105, 1327, 10.1073/pnas.0710217105 Cao, 2013, Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization, J Clin Pharm Therapeut, 38, 394, 10.1111/jcpt.12074 Lanao, 2004, Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates, J Antimicrob Chemother, 54, 193, 10.1093/jac/dkh261 Burkhardt, 2006, Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?, J Antimicrob Chemother, 58, 822, 10.1093/jac/dkl328 MacGowan, 2003, Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections, J Antimicrob Chemother, 51 Peloquin, 1997, Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide, Antimicrob Agents Chemother, 41, 2670, 10.1128/AAC.41.12.2670 Benvenuto, 2006, Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers, Antimicrob Agents Chemother, 50, 3245, 10.1128/AAC.00247-06 Sheeran, 2011, Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound, Langmuir, 27, 10412, 10.1021/la2013705